Bobby Sandage
Directeur Général chez Euclises Pharmaceuticals, Inc.
Profil
Bobby W.
Sandage currently works at Euclises Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2015, Immunophotonics, Inc., as Chairman from 2015, Electronic Drug Information Systems Solutions LLC, as Director, Arch Oncology, Inc., as Director, Geneoscopy, Inc., as Director, Lightchain Capital LLC, as Managing Director, NextRNA Therapeutics, Inc., as Director, AI Proteins, Inc., as Director, Endevica Bio, as Director from 2017, Paula And Rodger Riney Foundation, as Managing Director from 2020, Bioventures LLC, as Board Member from 2019, Cultivation Capital LLC, as General Partner from 2014, and Microbial Machines, Inc., as Board Member from 2022.
Dr. Sandage also formerly worked at Oncotelic Therapeutics, Inc., as Independent Director from 2016 to 2019, Genta, Inc., as Director, Gentium Srl, as Director from 2009 to 2012, Osteologix, Inc., as Director, Fortress Biotech, Inc., as President & Director from 2012 to 2013, DuPont Merck Pharmaceutical Co., as Associate Director-Project Management from 1989 to 1991, Osteologix Holdings Plc, as Director from 2005 to 2010, Dupont Critical Care, Inc., as Associate Medical Director-Medical Development from 1985 to 1989, American Critical Care Services, Inc., as Associate Medical Director from 1983 to 1986, Indevus Pharmaceuticals, Inc., as CSO, Executive VP-Research & Development from 1991 to 2009, Endo Health Solutions, Inc., as Vice President, Endo Pharmaceuticals, Inc., as Executive Vice President, Covidien Unlimited Co., as Vice President-Embedded Therapeutics from 2010 to 2011, and Merrell Dow Pharmaceuticals, Inc., as Principal.
Dr. Sandage received his undergraduate degree from The University of Arkansas and doctorate degree from Purdue University.
Postes actifs de Bobby Sandage
| Sociétés | Poste | Début |
|---|---|---|
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Président | 26/01/2015 |
Euclises Pharmaceuticals, Inc.
 Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Directeur Général | 27/01/2015 |
Electronic Drug Information Systems Solutions LLC
 Electronic Drug Information Systems Solutions LLC Packaged SoftwareTechnology Services Electronic Drug Information Systems Solutions LLC develops electronic drug information systems solutions. It operates a platform that gathers, filters, combines, and presents pharmaceutical intelligence. The firm provides data integration, analytics & presentation, forecasting, and project ranking services. The company is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | - |
Cultivation Capital LLC
 Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | 01/01/2014 |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Directeur/Membre du Conseil | - |
Lightchain Capital LLC
 Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
Geneoscopy, Inc.
 Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Directeur/Membre du Conseil | - |
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Directeur/Membre du Conseil | - |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Bobby Sandage
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Bobby Sandage
| Purdue University | Doctorate Degree |
| The University of Arkansas | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 25 |
|---|---|
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
| Osteologix, Inc. /Old/ | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| Dupont Critical Care, Inc. | |
Gentium Srl
 Gentium Srl Pharmaceuticals: MajorHealth Technology Gentium SRL manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy. | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ. | Health Technology |
Covidien Unlimited Co.
 Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI. | Health Technology |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
| Merrell Dow Pharmaceuticals, Inc. | |
Electronic Drug Information Systems Solutions LLC
Electronic Drug Information Systems Solutions LLC Packaged SoftwareTechnology Services Electronic Drug Information Systems Solutions LLC develops electronic drug information systems solutions. It operates a platform that gathers, filters, combines, and presents pharmaceutical intelligence. The firm provides data integration, analytics & presentation, forecasting, and project ranking services. The company is headquartered in St. Louis, MO. | Technology Services |
Cultivation Capital LLC
Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Finance |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
Lightchain Capital LLC
Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Technology Services |
Geneoscopy, Inc.
Geneoscopy, Inc. Miscellaneous Commercial ServicesCommercial Services Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO. | Commercial Services |
AI Proteins, Inc.
AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Health Technology |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | Health Technology |
Endevica Bio
 Endevica Bio BiotechnologyHealth Technology Endevica Bio is a biotechnology company that creates first-in-class peptide drug candidates to treat cachexia caused by diseases like cancer, renal failure, and congestive heart failure. The company is based in Columbia, MO. The company's technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to modulate activity of G-protein coupled receptors behind the blood-brain barrier. Endevica Bio's synthetic peptides are stable in plasma and have drug-like characteristics. The company was founded in 2009 by Dr. Kenneth Gruber, who wanted to create synthetic peptides that would show drug-like characteristics. Russ Potterfield has been the CEO of the company since 2020. | Health Technology |
| Microbial Machines, Inc. | |
| Paula And Rodger Riney Foundation | |
Bioventures LLC
 Bioventures LLC Pharmaceuticals: MajorHealth Technology Bioventures LLC is a pharmaceutical company that develops pharmaceutical products. The private company is based in Tulsa, OK and was founded in 2004. | Health Technology |
American Critical Care Services, Inc.
 American Critical Care Services, Inc. Personnel ServicesCommercial Services American Critical Care Services, Inc. provides reliable nurse staffing services for hospitals, facilities, and private duty. The private company is based in North Chesterfield, VA. The company offers registered nurses (RNs) and licensed practical nurses (LPNs) for private duty, as well as hospital RNs and certified nursing assistants (CNAs). | Commercial Services |